Viokase

This page contains recent news articles, when available, and an overview of Viokase but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Company Profile Report  -  Mar 22, 2008
Ultrase (Pancrelipase)/Ultrase MT (Pancrelipase); Viokase (Pancrelipase) ... Products:. Viokase (Pancrelipase). Phase I/Phase II Clinical Stage Products ... $50.00 - Revere Reports - Revere

Axcan Pharma Reports Solid Start to Fiscal 2008, With Revenue of...  -  Jan 31, 2008
The clinical work required for Axcan to submit an NDA for VIOKASE is currently ongoing and the Company expects to comply with the FDA guidelines within the ... marketwire.com

Axcan Pharma Sustains Growth in Fiscal 2007, With Record Revenue of …  -  Aug 9, 2007
Axcan is also progressing towards the submission of the NDA for VIOKASE, the only branded, uncoated pancreatic enzyme formulation available in the United ... marketwire.com

Axcan Pharma Continues its Solid Growth Trend, Closing Fiscal 2007 …  -  Nov 29, 2007
The clinical work required for Axcan to submit an NDA for VIOKASE is currently ongoing. For both products the Company expects to be compliant with the ... marketwire.com

Q4 2006 AXCAN PHARMA INC Earnings Conference Call - Part 2.  -  Dec 1, 2006
One of the things to realize if you look at the current pancreatic enzymes and so, also ULTRASE and VIOKASE the market is very satisfied with those products ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Axcan Announces Record Revenue of .8 Million for the Second Quarter...  -  May 4, 2006
Axcan has completed a Phase III study of VIOKASE that will serve as the basis of the New Drug Application. Additional studies on ULTRASE are currently ... RedOrbit

Strong Start for Axcan Pharma's Fiscal 2007, With Record Revenue of …  -  Feb 8, 2007
Axcan is currently advancing the completion of the New Drug Application ("NDA") of ULTRASE and VIOKASE, and is on track to meet the deadline for NDA ... ccnmatthews.com

Axcan Pharma Continues Solid Growth in Fiscal 2007, With Record …  -  May 10, 2007
Axcan is also progressing toward the completion of the NDA for VIOKASE, the only branded uncoated pancreatic enzyme formulation available in the United ... ccnmatthews.com

Event Brief of Q2 2007 AXCAN PHARMA INC Earnings Conference Call - …  -  May 11, 2007
This decrease was partially offset by costs specifically related to the NDAs for AXCA's two pancreatic enzyme products ULTRASE and VIOKASE. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Press Release: Axcan Pharma Inc. Review in Progress. - M2 Presswire |...  -  Jun 22, 2007
Drug Application (NDA) for ULTRASE, which increases our confidence ... s major projects follows: ULTRASE-VIOKASE In April 2004, the ... ... Pay-Per-View - M2 Presswire - HighBeam Research

Axcan Pharma fait rapport d'un solide début d'exercice pour 2008 avec...  -  Jan 31, 2008
Les travaux cliniques qu'Axcan doit réaliser pour soumettre une NDA sur VIOKASE se poursuivent actuellement et la Société prévoit se conformer aux lignes ... marketwire.com

Skin Ailments Might Be Linked to Organ Problems  -  Jul 31, 2008
The medicine prescribed was Viokase, and at about $160 per month for the rest of her life, we could not afford it. So we found a product on the Internet ... Pay-Per-View - Washington Post - ProQuest Archiver

Axcan Pharma poursuit sa solide croissance au cours de l'exercice...  -  May 10, 2007
Axcan progresse également en vue de finaliser la PDN sur VIOKASE, la seule formulation sous marque d'enzymes pancréatiques non-enrobées disponible aux ... ccnmatthews.com

DEAR PHARMACIST, Don't blame the bird for feeling sleepy  -  Dec 6, 2005
Other popular brand names are Ultrase, Creon and Viokase. I should mention that digestive enzymes of all sorts are sold over the counter for people with ... Pay-Per-View - Newsday - ProQuest Archiver

DEAR PHARMACIST SUZY COHEN  -  Dec 1, 2005
Other popular brand names are Ultrase, Creon and Viokase. For the sake of completeness, I should mention that digestive enzymes of all sorts are sold over ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver

Skin Ailments Might Be Linked to Organ Problems | Article from The …  -  Aug 3, 2008
The medicine prescribed was Viokase, and at about $160 per month for the rest of her life, we could not afford it. So we found a product on the Internet ... Pay-Per-View - Washington Post - HighBeam Research

Un début d'exercice 2007 solide pour Axcan Pharma avec des produits …  -  Feb 8, 2007
En avril 2004, la FDA a dûment avisé les fabricants de produits traitant l'insuffisance pancréatique que ces médicaments, qui incluent ULTRASE et VIOKASE, ... ccnmatthews.com

La tendance de croissance solide d'Axcan Pharma se poursuit, l'exercic...  -  Nov 29, 2007
Les travaux cliniques requis pour qu'Axcan soumette une NDA sur VIOKASE sont actuellement en cours. Pour chacun de ces produits, la Société prévoit se ... marketwire.com

Diário atual e selvagem  -  Jun 26, 2005
Diário selvagem é uma narrativa densa, com trechos até escrotos, parte bula de remédio: "Pancreatite Futebol Clube: Digesan, Tagamet e Viokase; meio mamão, ... Paraná-Online - Paraná-Online (Assinatura)

Miglitol (Systemic).(Drug overview)  -  Aug 1, 2006
Digestive enzymes (eg, Pancrease, Viokase, etc.) or Activated charcoal (eg, Insta-Char, Liqui-Char) -- Miglitol may not work as well when taken with these ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Q3 2006 AXCAN PHARMA INC Earnings Conference Call - Part 2.  -  Aug 11, 2006
On ULTRASE and VIOKASE, can you maybe elaborate on what's the nature of this additional clinical work that is currently being done prior to your first-half ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Miglitol (Systemic).  -  Feb 1, 2006
Digestive enzymes (eg, Pancrease, Viokase, etc.) or Activated charcoal (eg, Insta-Char, Liqui-Char) -- Miglitol may not work as well when taken with these ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Confinement in cage may be at root of dog's odd behavior  -  Jul 27, 2008
The medicine prescribed was Viokase. At about $160 per month for the rest of her life, we could not afford that. So we found a product on the Internet ... $2.00 - Daily Gazette - NewsBank

Axcan announces record revenue of $70.6 million for the first quarter...  -  Feb 9, 2006
Axcan has completed a Phase III study of VIOKASE that will serve as the basis of the New Drug Application. The Company expects to submit a New Drug ... $4.95 - PR Newswire - ECNext

Solvay 'still on path' for Creon  -  Aug 21, 2007
Other pancreatic insufficiency drugs that contain pancrelipase are Cotazym from Organon, Lipram from Global Pharmaceuticals, Viokase from Scandiphrm and ... In-PharmaTechnologist.com

How to take Miglitol from Consumer Reports Health.  -  Jan 5, 2007
...digestive enzymes (Viokase, Pancrease, or Ultrase), digoxin (Lanoxin), propranolol (Inderal), ranitidine (Zantac), and vitamins. ... consumerreports.org





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy